Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes

被引:48
|
作者
Monnier, Vincent M. [1 ,2 ]
Sun, Wanjie [3 ]
Gao, Xiaoyu [3 ]
Sell, David R. [1 ]
Cleary, Patricia A. [3 ]
Lachin, John M. [3 ]
Genuth, Saul [4 ]
机构
[1] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA
[3] George Washington Univ, Ctr Biostat, Rockville, MD USA
[4] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA
基金
美国国家卫生研究院;
关键词
AGEs; A1c; DCCT/EDIC; Coronary artery calcium; Intima media thickening; Cardiac indices; CARBOXYMETHYL-LYSINE; CROSS-LINKING; END-PRODUCTS; COMPLICATIONS; GLUCOSEPANE; GLYCOXIDATION; CALCIFICATION; INTERVENTIONS; ACCUMULATION; PARTICIPANTS;
D O I
10.1186/s12933-015-0266-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: We recently reported strong associations between eight skin collagen AGEs and two solubility markers from skin biopsies obtained at DCCT study closeout and the long-term progression of microvascular disease in EDIC, despite adjustment for mean glycemia. Herein we investigated the hypothesis that some of these AGEs (fluorescence to be reported elsewhere) correlate with long-term subclinical cardiovascular disease (CVD) measurements, i.e. coronary artery calcium score (CAC) at EDIC year 7-9 (n = 187), change of carotid intima-media thickness (IMT) from EDIC year 1 to year 6 and 12 (n = 127), and cardiac MRI outcomes at EDIC year 15-16 (n = 142). Methods: Skin collagen AGE measurements obtained from stored specimens were related to clinical data from the DCCT/EDIC using Spearman correlations and multivariable logistic regression analyses. Results: Spearman correlations showed furosine (early glycation) was associated with future mean CAC (p < 0.05) and CAC > 0 (p = 0.39), but not with CAC score < 100 vs. > 100. Glucosepane and pentosidine crosslinks, methylglyoxal hydroimidazolones (MG-H1) and pepsin solubility (inversely) correlated with IMT change from year 1 to 6(all P < 0.05). Left ventricular (LV) mass (cMRI) correlated with MG-H1, and inversely with pepsin solubility (both p < 0.05), while the ratio LV mass/end diastolic volume correlated with furosine and MG-H1 (both p < 0.05), and highly with CML (p < 0.01). In multivariate analysis only furosine (p = 0.01) was associated with CAC. In contrast IMT was inversely associated with lower collagen pepsin solubility and positively with glucosepane, Conclusions: In type 1 diabetes, multiple AGEs are associated with IMT progression in spite of adjustment for A1c implying a likely participatory role of glycation and AGE mediated crosslinking on matrix accumulation in coronary arteries. This may also apply to functional cardiac MRI outcomes, especially left ventricular mass. In contrast, early glycation measured by furosine, but not AGEs, was associated with CAC score, implying hyperglycemia as a risk factor in calcium deposition perhaps via processes independent of glycation.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Long-Term Incidence of Cardiovascular Disease across the Natural History of Type 2 Diabetes
    An, Jaejin
    Nichols, Gregory A.
    Qian, Lei
    Wei, Rong
    Harrison, Teresa
    Munis, Mercedes A.
    Li, Zhuoxin
    Weiss, Tracey
    Iglay, Kristy
    Rajpathak, Swapnil
    Reynolds, Kristi
    DIABETES, 2019, 68
  • [32] Early Trajectory of Estimated Glomerular Filtration Rate and Long-term Advanced Kidney and Cardiovascular Complications in Type 1 Diabetes
    Perkins, Bruce A.
    Bebu, Ionut
    Gao, Xiaoyu
    Karger, Amy B.
    Hirsch, Irl B.
    Karanchi, Harsha
    Molitch, Mark E.
    Zinman, Bernard
    Lachin, John M.
    de Boer, Ian H.
    DIABETES CARE, 2022, 45 (03) : 585 - 593
  • [33] Advanced glycation end products (AGEs) and the soluble receptor for AGE (sRAGE) in patients with type 1 diabetes and coeliac disease
    Bakker, S. F.
    Tushuizen, M. E.
    Gozutok, E.
    Ciftci, A.
    Gelderman, K. A.
    Mulder, C. J.
    Simsek, S.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2015, 25 (02) : 230 - 235
  • [34] Glucosepane and oxidative markers in skin collagen correlate with intima media thickness and arterial stiffness in long-term type 1 diabetes
    Sveen, Kari Anne
    Dahl-Jorgensen, Knut
    Stensaeth, Knut Haakon
    Angel, Kristin
    Seljeflot, Ingebjorg
    Sell, David R.
    Monnier, Vincent M.
    Hanssen, Kristian F.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2015, 29 (03) : 407 - 412
  • [35] Long-term cardiovascular prognosis of patients with type 1 diabetes after myocardial infarction
    Anne M. Kerola
    Anne Grete Semb
    Markus Juonala
    Antti Palomäki
    Päivi Rautava
    Ville Kytö
    Cardiovascular Diabetology, 21
  • [36] Long-term cardiovascular prognosis of patients with type 1 diabetes after myocardial infarction
    Kerola, Anne M.
    Semb, Anne Grete
    Juonala, Markus
    Palomaki, Antti
    Rautava, Paivi
    Kyto, Ville
    CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [37] Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with long-term intensive versus conventional therapy of type 1 diabetes -: Relevance of glycated collagen products versus HbA1c as markers of diabetic complications
    Monnier, VM
    Bautista, O
    Kenny, D
    Sell, DR
    Fogarty, J
    Dahms, W
    Cleary, PA
    Lachin, J
    Genuth, S
    DIABETES, 1999, 48 (04) : 870 - 880
  • [38] Clinical Profile of Long-term Survivors and Nonsurvivors with Type 1 Diabetes in India
    Mohan, Viswanathan
    Rani, Coimbatore Subramanian Shanthi
    Saboo, Banshi
    Mukhopadhyay, Satinath
    Chatterjee, Sudip
    Dharmarajan, Panneerselvam
    Gupta, Sunil
    Pendsey, Sharad
    Chandrakanta, Jha
    Umasankari, Ganesan
    Amutha, Anandakumar
    Salis, Sheryl
    Datta, Supriya
    Gupta, Prasanna Kumar
    Routray, Philips
    Jebarani, Saravanan
    Sastry, Nadiminty Ganapathi
    Venkatesan, Ulagamathesan
    Anjana, Ranjit Mohan
    Unnikrishnan, Ranjit
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 (02) : 120 - 129
  • [39] Long-term maintenance of efficacy of dapagliflozin in patients with type 2 diabetes mellitus and cardiovascular disease
    Leiter, L. A.
    Cefalu, W. T.
    de Bruin, T. W. A.
    Xu, J.
    Parikh, S.
    Johnsson, E.
    Gause-Nilsson, I.
    DIABETES OBESITY & METABOLISM, 2016, 18 (08): : 766 - 774
  • [40] Long-term Efficacy and Safety of Dapagliflozin in Patients with Type 2 Diabetes, Cardiovascular Disease, and Hypertension
    Cefalu, William T.
    Gause-Nilsson, Ingrid Ami
    De Bruin, Tjerk W. A.
    Sugg, Jennifer E.
    Parikh, Shamik J.
    Johnsson, Eva
    DIABETES, 2014, 63 : A286 - A286